Kura Oncology Inc - logo

Kura Oncology Inc - Company & Market Research Reports

Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 1258 Pages
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
New Frontiers in Cancer Therapies: Focus on Transcription Factors, GTPases, Phosphatases and GPCRs, 2018-2030 - Product Thumbnail Image

New Frontiers in Cancer Therapies: Focus on Transcription Factors, GTPases, Phosphatases and GPCRs, 2018-2030

  • Report
  • 200 Pages
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018

  • Report
  • 2103 Pages
From
Mitogen Activated Protein Kinase 3 (MAP Kinase 3 or Insulin-Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or ERK-1 or EC 2.7.11.24) - Pipeline Review, H1 2016 - Product Thumbnail Image

Mitogen Activated Protein Kinase 3 (MAP Kinase 3 or Insulin-Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or ERK-1 or EC 2.7.11.24) - Pipeline Review, H1 2016

  • Report
  • 39 Pages
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Report
  • 1275 Pages
From
Head And Neck Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H1 2018

  • Report
  • 1639 Pages
From
Mitogen Activated Protein Kinase 3 - Pipeline Review, H1 2018 - Product Thumbnail Image

Mitogen Activated Protein Kinase 3 - Pipeline Review, H1 2018

  • Report
  • 45 Pages
From
Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H1 2018 - Product Thumbnail Image

Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H1 2018

  • Report
  • 51 Pages
From
Mitogen Activated Protein Kinase 3 - Pipeline Review, H2 2017 - Product Thumbnail Image

Mitogen Activated Protein Kinase 3 - Pipeline Review, H2 2017

  • Report
  • 38 Pages
From
Mitogen Activated Protein Kinase 1 (MAP Kinase 1 or MAPK 1 or Extracellular Signal Regulated Kinase 2 or ERK-2 or Protein Tyrosine Kinase ERK2 or EC 2.7.11.24) - Pipeline Review, H1 2016 - Product Thumbnail Image

Mitogen Activated Protein Kinase 1 (MAP Kinase 1 or MAPK 1 or Extracellular Signal Regulated Kinase 2 or ERK-2 or Protein Tyrosine Kinase ERK2 or EC 2.7.11.24) - Pipeline Review, H1 2016

  • Report
  • 46 Pages
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Report
  • 2509 Pages
From
Colorectal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2018

  • Report
  • 2237 Pages
From
Prostate Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H1 2018

  • Report
  • 2069 Pages
From
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016

  • Report
  • 246 Pages
From
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insights, 2018 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insights, 2018

  • Drug Pipelines
  • 115 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • Report
  • 3034 Pages
From
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

  • Report
  • 665 Pages
From
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

  • Report
  • 226 Pages
From
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

  • Report
  • 663 Pages
From
Loading Indicator
adroll